Speaker 1: Life sciences and healthcare industry have far are a huge area of focus at the moment with an aging population, with diverse challenges in medication and delivery. It's a, it's a real challenge for the industry to keep up. One of the areas that we're able to really support is that rapid development from concept through production delivery, scale up from the idea through the regulations, whether it's inside a QMS whether it's subject to 13485 or FDA regulation, all of our solutions will support customers going along that journey. The, end result is a leaner more efficient process, faster time to market and more certainty around the validity of the solution, whether it's a medical device, whether it's a drug delivery system or a drug itself, in life sciences and healthcare. There's probably two trends traveling in opposite directions. One is the digitization of healthcare. So intelligently connected devices, whether it's whatever the blood sugar level is to determine how much insulin you need, the patient comfort level, whether the hand soap needs replacing because it's run out. The digital system is connected, can alert people So there's no wasted journeys or no wasted soap. For medication I think the trend is going to be faster and faster and faster development of drugs that get to market sooner will be the key, not 10 years or 15 years, probably not even five years. How quickly can we get a drug to market two years, 12 months. And that will be driven by using an end to end digital platform that will allow the idea to go through concept and scale up of final production.